Zdrowie i gospodarka · 11/03/1994

The Food and Drug Administration (FDA) and National Institute of Allergy and Infectious Diseases (NIAID) Announce Public Workshop on Clinical Trial Design Issues of Liposomal Antifungal Agents

The FDA and NIAID are hosting a public workshop to discuss clinical trial design issues of liposomal antifungal agents, aiming to assist pharmaceutical sponsors in designing study protocols and expediting drug development.